5 Trade Ideas for Friday, Aug 12
Four Stocks Worth Taking A Look At
Stock Trade Ideas for Friday, July 15
Why the Health Research Funded by the Pentagon is Unique and Valuable
Walter Pincus’s latest article published by the Washington Post criticizes the health research funding in the defense appropriations bill as both earmarked funding and unneeded duplicative funding. He is wrong. It Isn’t Earmarked Funding The defense health programs don’t come close to meeting the Administration’s own definition of an earmark. The Office of Management and [...]
Possible Bounce Plays for Thursday
4 Trade Setups To Watch
Stock Picks for Wednesday May 18, 2011
Stock Picks for Week of May 16th
Four Hot Casino Stocks
Friday Stocks To Watch
Stock Market alerts for Friday Mar 18
Top Solar Stocks to Watch this week
Analyst Bulls Up on Dendreon (DNDN, AMGN)
A bullish research call on Dendreon Corporation (NASDAQ: DNDN) by Gleacher & Co. has so far been unable to prevent some pullbacks along with a broader market that is spooked by international geopolitical events. Still, the research does lend credence to further upside for Dendreon based on its Provenge. While not a target in the [...]
Upside Reversal for Amgen
Todays sharp morning session upside reversal in Amgen AMGN is...
Amgen Blows Its Marketing Budget on Phil Mickelson Campaign
Stock Picks for Wednesday, January 05
Big Biotechs With The Most Upside for 2011 (AMGN, GILD, CELG, HGSI, DNDN, INCY, ACOR)
Bioheath Investor is creating some ongoing outlook pieces as 2010 ends so we have an outline of what to expect for 2011. We have already given the “Best of Big Biotech in 2010″ and now we want to focus on “The Big Biotechs With The Most Upside for 2011.” Using “Big Biotech” implies market caps [...]
Stock Picks for Thursday December 23
Stock Picks for Wednesday December 22
Fast Money Recap 12/17/10
Stock picks by each of the traders on the latest episode of “Fast Money.” (Fast Money Recaps at Online Traders’ Forum) Buy Altria Group (MO) (Anthony Scaramucci) Amgen (AMGN) (Jon Najarian) Boston Beer (SAM) (”expects a stock split”) (Terranova) Coach (COH) (Anthony Scaramucci) Coach (COH) (Jon Najarian) Hewlett-Packard (HPQ) (Finerman) Micron (MU) (Regis Philbin) Morgan Stanley (MS) (”but wouldn’t get short”) (Finerman) Nike (NKE) (Adami) Nike [...]
Stocks to watch for the 16th of December
Stocks to Watch for the 15th of December
Amgen Scores Indication in Prostate Cancer (AMGN, DNDN)
Amgen Inc. (NASDAQ: AMGN) is running higher after reporting on Monday evening that denosumab did delay the spread of prostate cancer to bones. The study opens up the possibility for another blockbuster revenue stream for the drug and then some with annual sales possibilities of more than $1 billion. Denosumab delayed the spread of prostate [...]
Top BioHealth Analyst Upgrades & Downgrades (AMGN, AZN, BAY, BIIB, CELG, EXAM, GILD, GSK, HGSI, LH, NVS, PFE, UTHR, WCRX)
We have seen many research calls from Wall Street analysts with upgrades, downgrades, and initiations this Tuesday in the world of biotech, pharmaceuticals, and biohealth. Some of the key calls we have seen are as follows: Amgen Inc. (NASDAQ: AMGN) Started as Neutral w/ $58 target at Credit Suisse. AstraZeneca (NYSE: AZN) Cut to Underperform [...]
The Hottest Stocks To Watch Tomorrow
Amgen’s Xgeva Approved
Amgen Inc. (NASDAQ:AMGN) received a major boost recently with the company gaining US Food and Drug Administration (FDA) approval for Xgeva (denosumab) for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. Significant Expansion in Patient Population With this approval, Amgen should see a significant expansion in the patient population [...]
Stocks Picks for Friday, November 19
Stocks to Keep on Your Radar Screen for Thursday
NGM Biopharmaceuticals changes CEOs
NGM Biopharmaceuticals Inc. hired William Rieflin as CEO, replacing David Goeddel, who remains chairman of the South San Francisco business. (AMGN)
Standout Options Trading in Amgen (AMGN, TEVA)
Amgen Inc. (NASDAQ: AMGN) has seen some unusual options trading and it appears to be based around some upcoming FDA events and on its trends. Joe Kunkle of OptionsHawk.com noted, “The January $52.50/$47.50 ratio put spread for 3,500X7,000 at $0.95 was an opening trade on September 30 after checking the open interest, and a bearish [...]
What Google thinks of Amgen Inc.
Seasonality Analysis of AMGN
Historical data for AMGN
Amgen Inc. at ValueWiki
Experimental Head and Shoulders chart patterns identified today
Experimental Inverted Head and Shoulders chart patterns identified today
Stocks with Positive Correlation to AMGN
Stocks with Negative Correlation to AMGN
Previous symbol is AMGM
Next symbol is AMGO